A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

Abstract Background The objective of this study was to retrospectively compare initial procedure and 12-month follow-up hospitalization charges and resource utilization (lengths of stay; LOS) for lumbar fusion surgeries using either recombinant human bone morphogenetic protein-2 (rhBMP-2) or a cellu...

Full description

Bibliographic Details
Main Authors: Bradley Wetzell, Julie B. McLean, Mark A. Moore, Venkateswarlu Kondragunta, Kimberly Dorsch
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Cellular bone allograft
CBA
Economics
Lumbar fusion
Infuse
Recombinant human bone morphogenetic protein-2
Online Access:http://link.springer.com/article/10.1186/s13018-020-02078-7

Internet

http://link.springer.com/article/10.1186/s13018-020-02078-7

Similar Items